Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer
Aim: Assess factors associated with EGFR TKI initiation among patients with metastatic non-small-cell lung cancer (mNSCLC). Patients & methods: Medicare Part D patients diagnosed with non-squamous mNSCLC and starting an EGFR TKI within 1 year of diagnosis were selected from the Surveillance, Epi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Future Medicine Ltd.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |